TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2485066

Group type: EXPERIMENTAL
Intervention: H142 at 1.0 mg/kg/h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: H142 at 2.5 mg/kg/h
Number of subjects: 9

Group type: COMPARATOR
Intervention: 5% dextrose (control)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: H142 (both doses)
Number of subjects: 9
Study: 28749571

Group type: EXPERIMENTAL
Intervention: Intravenous L-ornithine L-aspartate (LOLA), 30g daily for 5 days
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 27273854

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard conventional care pathway
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both ERAS and Standard care
Number of subjects: 0
Study: 25803546

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control capsules
Number of subjects: 98
Study: 23593611

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a plus ribavirin therapy (Clinical Trial group)
Number of subjects: 272

Group type: COMPARATOR
Intervention: peginterferon alfa-2a plus ribavirin therapy (Cohort group)
Number of subjects: 272
Study: 19932589

Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 20

Group type: COMPARATOR
Intervention: ProMECE-CytaBOM infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexrazoxane supplementation
Number of subjects: 20
Study: 18442542

Group type: EXPERIMENTAL
Intervention: PAS-Port system
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (hand-sewn technique)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PAS-Port group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study: 16799778

Group type: EXPERIMENTAL
Intervention: Anti-TNFalpha therapy
Number of subjects: 9
Study: 12520631

Group type: EXPERIMENTAL
Intervention: Nizatidine CR 150 mg bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nizatidine CR 300 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nizatidine IR 150 mg bid
Number of subjects: 0
Study: 10644535

Group type: EXPERIMENTAL
Intervention: Low energy availability (A = 45 kcal kg LBM(‐1) x day(‐1))
Number of subjects: 16

Group type: COMPARATOR
Intervention: Exercise stress (E = 30 kcal x kg LBM(‐1) x day(‐1))
Number of subjects: 16
Study: 9127064

Group type: COMPARATOR
Intervention: Prone positioner
Number of subjects: 20
Study: 7934692

Group type: EXPERIMENTAL
Intervention: Preoperative iliohypogastric ilioinguinal nerve block (IINB) with 0.25% bupivacaine at 1 mg/Kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postoperative iliohypogastric ilioinguinal nerve block (IINB) with 0.25% bupivacaine at 1 mg/Kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 30
Study: 3782654

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29912077

Group type: EXPERIMENTAL
Intervention: Combined weight training program (CT) using speed-lifts and plyometrics
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flexible barbell (FB) training with a fixed mass of 56.82 kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Margaria-Kalamen stair power test
Number of subjects: 28
Study: 27573565

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (MNTX)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Response to MNTX treatment
Number of subjects: 229

Group type: COMPARATOR
Intervention: No response to MNTX treatment
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: MNTX
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Albumin ≥3.5
Number of subjects: 229

Group type: COMPARATOR
Intervention: MNTX vs. placebo in patients with advanced illness other than cancer
Number of subjects: 229
Study: 24679062

Group type: EXPERIMENTAL
Intervention: Aspirin (200 mg before surgery, 100 mg daily for 30 days in initiation stratum; 100 mg daily for 7 days in continuation stratum)
Number of subjects: 10010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10010

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10010
Study: 22489519

Group type: EXPERIMENTAL
Intervention: Ultra-early application with intermittent pneumatic compression (IPC) starting 3 days before operation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postoperative application with intermittent pneumatic compression (IPC) starting on the day of operation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ultra-early application with IPC
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postoperative application with IPC
Number of subjects: 80
Study: 20146569

Group type: EXPERIMENTAL
Intervention: Hyperthermia treatment planning guided steering (HGS) during the second and fourth treatments
Number of subjects: 36

Group type: COMPARATOR
Intervention: Rotterdam Empirical Steering Guidelines (RESG) during the second and third treatments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hyperthermia treatment planning guided steering (HGS) during the fourth and fifth treatments
Number of subjects: 36

Group type: COMPARATOR
Intervention: Rotterdam Empirical Steering Guidelines (RESG) during the fourth and fifth treatments
Number of subjects: 36
Study: 18272794

Group type: EXPERIMENTAL
Intervention: EE + LLLT
Number of subjects: 52

Group type: COMPARATOR
Intervention: EE + placebo LLLT
Number of subjects: 52
Study: 15918381

Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (PLMA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laryngeal tube S (LTS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oesophageal‐tracheal combitube (OTC)
Number of subjects: 90
Study: 12875680

Group type: EXPERIMENTAL
Intervention: HBIG (200 IU or 400 IU intramuscularly at 3, 2 and 1 month before delivery)
Number of subjects: 980

Group type: COMPARATOR
Intervention: Control (no specific treatment)
Number of subjects: 980
Study: 10597557

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms.kg-1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 120
Study: 8682484

Group type: EXPERIMENTAL
Intervention: Pefloxacin (800mg per day) plus Klindamicin (2,400mg per day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cefoxitin (4,000mg per day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pefloxacin plus Klindamicin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 75
Study: 1357350

Group type: EXPERIMENTAL
Intervention: Intracervical lignocaine
Number of subjects: 0
Study: 3899772

Group type: EXPERIMENTAL
Intervention: Penbutolol 40 mg once a day
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Prenylamine 60 mg t.i.d.
Number of subjects: 17
Study: 31332025

Group type: EXPERIMENTAL
Intervention: Standard treatment combined with breathing exercise rehabilitation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 64
Study: 29501470

Group type: EXPERIMENTAL
Intervention: 1 session/week of group exercise (30-minute sessions)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2 sessions/week of group exercise (30-minute sessions)
Number of subjects: 27
Study: 25809790

Group type: EXPERIMENTAL
Intervention: Couple-based treatment with emphasis on 'we' language
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Couple-based treatment with emphasis on 'you' and 'I' language
Number of subjects: 188
Study: 24742032

Group type: EXPERIMENTAL
Intervention: Tailored multi-faceted improvement implementation programme
Number of subjects: 124

Group type: COMPARATOR
Intervention: National guideline and feedback letters (control group)
Number of subjects: 124
Study: 22080174

Group type: EXPERIMENTAL
Intervention: 3.75 μg H5N1 haemagglutinin antigen
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 7.5 μg H5N1 haemagglutinin antigen
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Cross-reactive antibody response
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Persistence of antibodies
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Safety of the vaccine
Number of subjects: 110
Study: 20730486

Group type: EXPERIMENTAL
Intervention: Exemestane withdrawal
Number of subjects: 206

Group type: COMPARATOR
Intervention: Tamoxifen withdrawal
Number of subjects: 206

Group type: COMPARATOR
Intervention: Exemestane treatment
Number of subjects: 206

Group type: COMPARATOR
Intervention: Post-treatment fracture rates
Number of subjects: 206
Study: 17656657

Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 16136769

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg, twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Montelukast (once daily)
Number of subjects: 0
Study: 12351465

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily for 8 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Corn oil (4 g daily for 8 weeks)
Number of subjects: 42
Study: 10614749

Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (confined to bed for four days)
Number of subjects: 50
Study: 7753691

Group type: EXPERIMENTAL
Intervention: Eight-step process improvement model for nursing home-acquired pneumonia management
Number of subjects: 0
Study: 1780394

Group type: EXPERIMENTAL
Intervention: Brief psychological treatment (problem-solving) given by a psychiatrist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Any treatment of the GP's choice (psychological or pharmacological)
Number of subjects: 0
Study: 6761102

Group type: EXPERIMENTAL
Intervention: High calorie daily supplement (800 kcal and 40 g protein)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30944021

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (70 micrograms daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30387859

Group type: EXPERIMENTAL
Intervention: Chewed Oxycodone DETERx fasted
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Chewed Oxycodone DETERx fed
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intact Oxycodone DETERx fasted
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intact Oxycodone DETERx fed
Number of subjects: 71

Group type: COMPARATOR
Intervention: Crushed IR oxycodone fasted
Number of subjects: 71
Study: 26518108

Group type: EXPERIMENTAL
Intervention: Counselling protocol with the use of the monitoring-and-feedback tool (group 1, n=65)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Counselling protocol without the use of the monitoring-and-feedback tool (group 2, n=66)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Counselling protocol (both groups)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Counselling protocol with the use of the monitoring-and-feedback tool (group 1)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Counselling protocol without the use of the monitoring-and-feedback tool (group 2)
Number of subjects: 131
Study: 24491000

Group type: COMPARATOR
Intervention: Skin staples for securing mesh
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polypropylene suture for securing mesh
Number of subjects: 0
Study: 23211228

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (90 minutes/day, 2 days/week for 6 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (health promotion education classes, 2 classes over 6 months)
Number of subjects: 50
Study: 21309477

Group type: COMPARATOR
Intervention: Closed circuit anaesthesia (CCA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Semi-closed circuit anaesthesia (SCA) 4 l/min
Number of subjects: 50
Study: 17540986

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy monitoring during deep hypothermia with circulatory arrest
Number of subjects: 24

Group type: COMPARATOR
Intervention: Near-infrared spectroscopy monitoring during moderate hypothermia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Near-infrared spectroscopy monitoring during deep hypothermia with low flow
Number of subjects: 24
Study: 16244028

Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine with 8.4% NaHCO3 (group large dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine with 1.4% NaHCO3 (group small dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air (group air)
Number of subjects: 60
Study: 12364905

Group type: EXPERIMENTAL
Intervention: Safer Sex Workshop
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 394
Study: 10209729

Group type: EXPERIMENTAL
Intervention: Fornix-based conjunctival flap
Number of subjects: 29

Group type: COMPARATOR
Intervention: Limbal-based conjunctival flap
Number of subjects: 29
Study: 7607749

Group type: EXPERIMENTAL
Intervention: Polyol gums (xylitol and sorbitol, or their combinations)
Number of subjects: 1787

Group type: EXPERIMENTAL
Intervention: 100% xylitol gums
Number of subjects: 1787

Group type: COMPARATOR
Intervention: Other treatments (including sucrose gum)
Number of subjects: 1787
Study: 2230911

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g i.v.) at the time of anesthesia
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gentamicin (80 mg i.v.) at the time of anesthesia and two additional doses every 8 hours
Number of subjects: 52
Study: 112630

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31987555

Group type: EXPERIMENTAL
Intervention: P30 (30 s rest)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P60 (60 s rest)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P90 (90 s rest)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P120 (120 s rest)
Number of subjects: 15
Study: 31702486

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg twice daily for 4 days followed by metoclopramide 20 mg
Number of subjects: 12
Study: 28842913

Group type: EXPERIMENTAL
Intervention: Family conflict at 14 months
Number of subjects: 2876
Study: 26237354

Group type: EXPERIMENTAL
Intervention: Inhaled Interferon gamma (IFN‐γ) for 80 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 10
Study: 23351309

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) 2.4 g/d
Number of subjects: 20

Group type: COMPARATOR
Intervention: Guanidinoacetic acid (GAA) 2.4 g/d with methyl donors (1.6 g/d of betaine HCl, 5 μg/d of vitamin B12, 10 mg/d of vitamin B6, 600 μg/d of folic acid)
Number of subjects: 20
Study: 21148235

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir 300/100 mg once daily
Number of subjects: 883

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir 400/100 mg twice daily
Number of subjects: 883
Study: 19258430

Group type: EXPERIMENTAL
Intervention: rhGH (0.09 IU/kg body weight, 6 days/week for 3 weeks)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: rhGH withdrawal
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no rhGH treatment)
Number of subjects: 109
Study: 17210983

Group type: EXPERIMENTAL
Intervention: Prompt endoscopy for patients over 55 years of age or with alarm symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various treatment options for dyspepsia
Number of subjects: 0
Study: 15650345

Group type: COMPARATOR
Intervention: Premenopausal women with hFH
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Postmenopausal women with hFH
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Postmenopausal hFH women with abnormal TG response (hFH-A)
Number of subjects: 33
Study: 11194109

Group type: EXPERIMENTAL
Intervention: Immediate HBO (iHBO)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Delayed HBO (dHBO)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 9392462

Group type: EXPERIMENTAL
Intervention: CECT criteria
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: APACHE II score
Number of subjects: 35
Study: 7827373

Group type: EXPERIMENTAL
Intervention: octreotide (100 micrograms) s.c. administered 30 minutes before meals for 7 days
Number of subjects: 5

Group type: COMPARATOR
Intervention: CCK-PZ and secretin (0.01 CHR U/kg/min)
Number of subjects: 5
Study: 3278672

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CyA, 5 mg/kg/day)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Azathioprine (Aza, 2.5 mg/kg/day)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CyA)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Azathioprine (Aza)
Number of subjects: 194
Study: 28993264

Group type: EXPERIMENTAL
Intervention: Dual long-acting bronchodilator (umeclidinium/vilanterol - UME/VIL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Muscarinic-antagonist component (umeclidinium - UME)
Number of subjects: 14
Study: 29137696

Group type: EXPERIMENTAL
Intervention: Self-knee massage with ginger oil (twice a week)
Number of subjects: 68
Study: 26205973

Group type: EXPERIMENTAL
Intervention: Rhea's method for estimating pneumothorax size
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Choi's method for estimating pneumothorax size
Number of subjects: 80
Study: 23953645

Group type: EXPERIMENTAL
Intervention: POL (P/S ratio 0.27)
Number of subjects: 15

Group type: COMPARATOR
Intervention: AHA (P/S ratio 1.00)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PCAN (P/S ratio 1.32)
Number of subjects: 15
Study: 22162649

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 5
Study: 19032134

Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg three times daily for 5-7 days
Number of subjects: 209

Group type: COMPARATOR
Intervention: Tramadol 50 mg three times daily for 5-7 days
Number of subjects: 209
Study: 17115157

Group type: EXPERIMENTAL
Intervention: AZD5438 60 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AZD5438 80 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AZD5438 160 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AZD5438 (various doses)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AZD5438
Number of subjects: 23
Study: 15020389

Group type: EXPERIMENTAL
Intervention: Access to clinical guidelines via the Internet or CD-ROM (Intervention group, n = 38)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Not having access to clinical guidelines (Control group, n = 34)
Number of subjects: 72
Study: 11357205

Group type: EXPERIMENTAL
Intervention: Improved water container with a cover and a spout
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (standard water collection method)
Number of subjects: 400
Study: 9143791

Group type: EXPERIMENTAL
Intervention: Urodilatin (n = 7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 14
Study: 8094111

Group type: EXPERIMENTAL
Intervention: Active taper (prednisolone 5 mg tablets)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo taper (identical placebo tablets)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Active taper
Number of subjects: 35
Study: 3304600

Group type: EXPERIMENTAL
Intervention: Moxalactam plus ticarcillin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Tobramycin plus ticarcillin
Number of subjects: 83
Study: 30909214

Group type: EXPERIMENTAL
Intervention: Visit-to-visit blood pressure variability (VVV)
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure coefficient of variation (CV)
Number of subjects: 392
Study: 29247782

Group type: EXPERIMENTAL
Intervention: Daily supplementation with 1000 IU of vitamin D and 500 mg of calcium for six months
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Daily supplementation with 1000 IU of vitamin D and 500 mg of calcium
Number of subjects: 106
Study: 26712558

Group type: EXPERIMENTAL
Intervention: Aminophylline (theophylline salt formulation)
Number of subjects: 71
Study: 24422912

Group type: EXPERIMENTAL
Intervention: 20-session rTMS conditioning with 10-session 1 Hz rTMS over contralesional M1 followed by 10-session iTBS over ipsilesional M1
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham stimulation identical to Group A
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20-session rTMS conditioning with 10-session iTBS over ipsilesional M1 followed by 10-session 1 Hz rTMS over contralesional M1
Number of subjects: 48
Study: 22564353

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 159
Study: 20193093

Group type: EXPERIMENTAL
Intervention: cNFO (northern fish oil with high POP content)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: deNFO (decontaminated northern fish oil)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: SFO/RO/SO (blend of southern fish oil, rapeseed and soybean oils)
Number of subjects: 3
Study: 18268511

Group type: EXPERIMENTAL
Intervention: Atkins diet
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Zone diet
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Ornish diet
Number of subjects: 181
Study: 15673389

Group type: EXPERIMENTAL
Intervention: Mental stress produced by Stroop's color word conflict test (CWT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Autonomic tone inhibition (ATI) with propranolol (0.15 mg/kg) and atropine (0.02 mg/kg)
Number of subjects: 23
Study: 12149603

Group type: EXPERIMENTAL
Intervention: Calcium alginate dressing
Number of subjects: 77

Group type: COMPARATOR
Intervention: Vaseline gauze dressing
Number of subjects: 77
Study: 10208192

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol (42 microg twice daily)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide (36 microg four times a day)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Inhaled placebo (2 puffs four times a day)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol
Number of subjects: 411
Study: 7788426

Group type: EXPERIMENTAL
Intervention: Oral atovaquone for mild to moderate PCP
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Oral atovaquone for severe PCP
Number of subjects: 940
Study: 2082317

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg plus Codeine 60 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 402794

Group type: EXPERIMENTAL
Intervention: TRH 600 mug
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10